Should recanalization devices only be restricted to clinical trials?
10.3760/cma.j.issn.1673-4165.2010.02.016
- VernacularTitle:血管再通装置应仅限于临床试验吗?
- Author:
Kejiang SU
;
Wei ZHANG
- Publication Type:Journal Article
- Keywords:
Stroke;
Brain ischemia;
Thrombolytic therapy;
Embolectomy;
Clinical trials as topic
- From:
International Journal of Cerebrovascular Diseases
2010;18(2):157-160
- CountryChina
- Language:Chinese
-
Abstract:
The application of recanalization devices in patients with acute iscbemic stroke has significantly increased the rate of vascular recanalization, however it does not significantly improve the outcome of patients. So, there have been controversies whether continue to restrict recanalization devices to clinical trials or direct transition to clinical practice in the absence of randomized controlled trial evidence.
